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2Abstract
The Rho family GTPase Rac acts as a molecular switch for signal transduction to regulate various cellular
functions.  Mice deficient in the hematopoietic-specific Rac2 isoform exhibit agonist-specific defects in
neutrophil chemotaxis and superoxide production, despite expression of the highly homologous Rac1
isoform.  To examine whether functional defects in rac2-/- neutrophils reflect effects of an overall
decrease in total cellular Rac or an isoform-specific role for Rac2, retroviral vectors were used to express
exogenous Rac1 or Rac2 at levels similar to endogenous.  In rac2-/- neutrophils differentiated from
transduced myeloid progenitors in vitro, increasing cellular Rac levels by expression of either exogenous
Rac1 or Rac2 increased fMLP- or phorbol ester-stimulated NADPH oxidase activity.  Of note, placement
of an epitope tag on N-terminus of Rac1 or Rac2 blunted reconstitution of responses in rac2-/- neutrophils.
In rac2-/- neutrophils isolated from mice transplanted with Rac-transduced bone marrow cells, superoxide
production and chemotaxis were fully reconstituted by expression of exogenous Rac2, but not Rac1.  A
chimeric Rac1 protein in which the Rac1 C-terminal polybasic domain, which contains 6 lysines or
arginines, was replaced with that of the human Rac2 polybasic domain containing only three basic
residues, also reconstituted superoxide production and chemotaxis, whereas expression of a Rac2
derivative in which the polybasic domain was replaced with that of Rac1 did not, and also resulted in
disoriented cell motility.  Thus, the composition of the polybasic domain is sufficient for determining Rac
isoform specificity in the production of superoxide and chemotaxis in murine neutrophils in vivo.
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3Introduction
Neutrophils are important effector cells in the host response to bacterial and fungal pathogens and
are endowed with chemotactic and microbicidal functions that are activated by signal transduction
pathways downstream of receptors for inflammatory and microbial stimuli (1).  Migration from blood
vessels to inflamed sites is initiated by various chemoattractants including chemokines secreted by host
cells and by bacterial products such as fMLP.  Superoxide produced by the neutrophil NADPH oxidase is
the precursor to toxic reactive oxidants important for normal microbial killing.
Rac GTPases, members of the Rho family of small GTPases, play a central role in regulating
neutrophil chemotaxis, superoxide production, and other neutrophil functions (2).  Rho GTPases act as
molecular switches in signaling pathways, alternating between activated GTP-bound and inactive GDP-
bound states.  In unstimulated cells, the GDP-bound form of Rac is bound to Rho guanine-nucleotide
dissociation inhibitor (Rho-GDI) which inhibits nucleotide exchange and maintains Rac-GDP in the
cytoplasm.  Upon stimulation, Rac translocates to the membrane where agonist-activated guanine
nucleotide exchange factors mediate the exchange of GDP for GTP, resulting in a conformational change
that permits Rac binding to downstream target proteins (3).  Rac has three isoforms, the ubiquitously
expressed Rac1, a hematopoietic cell-specific isoform Rac2, and Rac3 which appears to be expressed in a
variety of tissues but not phagocytes (4-8).  The amino acid sequence of murine Rac1 is identical to
human Rac1, and murine Rac2 differs by only two amino acids from human Rac2, with a conservative
substitution of aspartate instead of glutamate at position 148 and a proline instead of an alanine at position
188 (5,6).  Rac1 and Rac2 have 92% identical amino acid sequences.  These two isoforms have an
identical effector domain (amino acids 26 - 45), which is a critical site of interaction with both guanine
nucleotide exchange factors and downstream protein targets.  However, long-range effects exerted by
distant isoform-divergent amino acids may alter the flexibility of the effector domain to produce different
affinities of Rac1 and Rac2 for these proteins (9).  The greatest sequence divergence between Rac1 and
Rac2 is in the C-terminal polybasic domain (residues 183 - 188), which is adjacent to a prenylated
cysteine residue that can insert into cellular membranes.  Rac1 has six adjacent basic residues in the
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4polybasic domain (KKRKRK) whereas Rac2 has only three basic residues interspersed by neutral amino
acids (RQQKRA/P) (Fig. 1a).  The polybasic domain mediates differential localization of overexpressed
Rac1 and Rac2 to fibroblast and epithelial cell membranes (10), and contributes to differential
interactions with at least one downstream target of activated Rac GTPases, the serine-threonine kinase
PAK1 (11).1
Studies in murine Rac2-deficient neutrophils and neutrophils from a patient with a dominant-
negative mutation in Rac2 suggest that this isoform is essential for normal neutrophil function (8,12-15).
Although murine neutrophils have similar amounts of Rac1 and Rac2 (8), genetic deletion of Rac2 results
in severely impaired F-actin polymerization and chemotaxis in response to chemoattractants, decreased L-
selectin-mediated adhesion, and reduced superoxide production in response to fMLP, phorbol ester, and
IgG opsonized sheep red blood cells (8,12,15).  Heterozygous rac2+/- murine neutrophils have
intermediate activity between rac2+/+ and rac2-/- neutrophils in F-actin formation, chemotaxis, and
superoxide production (8).  In human neutrophils, which have predominantly Rac2, (16) expression of a
dominant-negative Rac2 results in cellular defects similar to those seen in rac2-/- murine neutrophils
(13,14).  Although Rac1-null murine neutrophils also exhibit decreased actin cytoskeleton assembly and a
modest decrease in directed migration, superoxide production is normal in contrast to Rac2-null
counterparts (17).  These findings suggest that Rac1 and Rac2 play distinct roles in regulating neutrophil
functions.  Alternatively, the defects in Rac2-deficient neutrophils could reflect effects of an overall
reduction in cellular Rac levels.
The goal of the current study was to examine whether the impaired functions of Rac2-null
neutrophils result from a relative cellular deficiency of total Rac or an isoform-specific role for Rac2 that
is mediated by specific sequences.  Retroviral vectors were used to express exogenous Rac1 or Rac2 in
rac2-/- neutrophils at levels similar to endogenous.  Increasing Rac levels by expression of either
exogenous Rac1 or Rac2 enhanced NADPH oxidase activity in rac2-/- neutrophils differentiated in vitro
with growth factors.  However, we found that only expression of exogenous Rac2, but not Rac1, fully
reconstituted defects in NADPH oxidase activity and chemotaxis in neutrophils harvested from rac2-/-
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5mice transplanted with transduced rac2-/- marrow cells.  This result could be recapitulated using a
derivative of Rac1 in which the polybasic domain was substituted with the corresponding region from
human Rac2, and conversely, expression of Rac2 chimeric for the polybasic Rac1 domain failed to rescue
defects in rac2-/- neutrophils, and resulted in disoriented motility.  Thus, the polybasic domain is sufficient
to confer isoform-specific Rac functions in regulating neutrophil chemotaxis and NADPH oxidase
activity.
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6Methods
Reagents and buffers
A polyclonal Rac2 antibody was previously raised in rabbits (18) and a mouse mAb against Rac1
was purchased from Upstate Biotechnology (Lake Placid, NY).  A rabbit polyclonal for p38MAPK was
obtained from Cell Signaling Inc.  PBS (pH 7.2), ddH2O, Glycerol, alpha MEM and IMDM medium,
penicillin, streptomycin and HEPES (125mM, pH 7.5) were from Life Technologies (Grand Island, NY).
Fetal calf serum (FCS) was from Hyclone laboratory (Logan UT).  Rat SCF, murine IL-6, and murine IL-
3 were from Peprotech (RockyHill, NJ), human MDGF and human G-CSF were from Amgen.  CH-296
was from Takara Bio (Otsu, Japan).  Other chemicals were purchased from Sigma (St. Louis, MO) unless
otherwise stated.  Buffers used in this study included PBS with 0.9mM CaCl2, 0.5mM MgCl2, and 7.5mM
glucose (PBSG), Triton IPB lysis buffer (20mM Tris-Cl pH 8.0, 150mM NaCl, 1mM EDTA, and 1%
Triton X-100, 20ug/ml chymostain, 2mM PMSF, 10uM leupeptin, and 1mM 4-(2-aminoethyl
benzenesulfonyl fluoride).  All reagents are endotoxin-free grade.  96-well plates were from Becton
Dickinson (Franklin Lakes, NJ).
Mice
Mice were maintained under specific pathogen-free conditions.  Wild type (WT) mice used in this
study were 8-10 week old male or female C57/Bl6J mice purchased from Jackson Laboratory Inc.  Rac2-/-
mice were previously generated (15) by targeted homologous recombination to disrupt the Rac2 gene.
Rac2-/- mice used here were 8-10 week old male or female mice that had been backcrossed onto the
C57/Bl6J for more than 11 generations.
Retroviral vectors for expression of Rac proteins
An MSCV retroviral backbone with a linked expression cassette for puromycin-N-acetyl-
transferase (PAC) (19), MSCV-pac, was a kind gift from R. Hawley (American Red Cross, Rockville,
MD).  The MIEG3 retroviral vector was derived from the MSCV series, and contains an internal
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7ribosome entry sequence (IRES) linked to a cDNA for the enhanced green fluorescent protein (EGFP)
instead of an antibiotic-resistance expression cassette (13).  Murine Rac1 and Rac2 cDNA's flanked by
BamHI and XbaI restriction sites were originally generated using RT-PCR from RNA prepared from the
RAW 264.7 mouse macrophage cell line.  The flanking restriction sites were changed to XhoI, along with
creation of a Kozak sequence at the initiator ATG, using oligonucleotide primers and PCR, and cloned
into the XhoI site in MSCV-Pac and MIEG3 (Fig. 1b).  The murine Rac1 or Rac2 cDNA's with an N-
terminal hemagglutinin (HA) or FLAG epitope tag (13,20), respectively, were also cloned into MSCV-
pac (Fig. 1b).  The human Rac1 cDNA in which the Rac2 polybasic domain was replaced with that of
Rac1 (Rac1-2) and the human Rac2 cDNA in which the polybasic domain was replaced with that of Rac1
(Rac2-1) were previously described (11).  PCR was used to place EcoRI and XhoI linkers at the 5' and 3'
ends, respectively, and each was subcloned into the corresponding sites in MIEG3 (Fig 1).  Details of
oligonucleotide primers used for PCR amplicications are provided upon request.  For all PCR-amplified
cDNAs, DNA sequencing was performed to verify the fidelity of amplification.   Vector plasmids were
transfected using calcium phosphate into ecotropic Phoenix packaging cells (provided by Gary Nolan,
Stanford University; ATCC # SD3444) and retroviral vector supernatants collected in alpha-MEM with
20% FCS.
Transduction of murine bone marrow cells with retroviral vectors for expression of Rac proteins,
Retroviral transduction of WT or rac2-/- murine BM was generally as previously described (21),
with the following modifications.  Three days following injection of 150 mg/kg 5-fluorouracil (5-FU) into
bone marrow (BM) donors, BM cells were taken from femurs and tibias by flushing with alpha-MEM.
The day of BM harvest was considered Day 0.  BM cells were pelleted and resuspended in 10ml of red
blood cell lysis solution (155mM NH4Cl, 10mM KHCO3, 100µM EDTA in H2O, pH7.4) in each tube,
and kept at room temperature for 3min.  Cells were then centrifuged and resuspended in either TD
medium A (alpha-MEM with 20% serum, 100 ng/ml rat SCF, 100 ng/ml human MDGF, 100 ng/ml
human G-SCF and 2% penicillin/streptomycin) or TD medium B (alpha-MEM with 20% serum, 100
 at Indiana U
niversity School of M
edicine on M
arch 27, 2014
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
8ng/ml rat SCF, 100 units/mlhuman IL-6 and 2% penicillin/streptomycin) for pre-stimulation for 48 hours.
On day 2, 3, and 4, cells were transduced every 24 hours with retrovirus supernatant on 6-well non-treated
culture plates that were coated with CH296 (4 µg/cm2) by overnight incubation at 4C˚ prior to virus
infection.   For each round of transduction, cells in suspension were spun down, resuspended in fresh
retrovirus supernatant containing either TD medium A or B and returned to the corresponding well and
incubated for 24 hours.  MSCV-pac vectors were used to transduce cells for in vitro differentiation in the
presence of puromycin, and MIEG3 vectors were used to transduce cells that were sorted for EGFP
fluoresence and transplanted into lethally irradiated recipient mice.  There was no difference between
these TD medium A or B in either the transduction efficiency or subsquent in vitro differentiation and
functional assays.  Medium without virus was used for mock transduction.  On day 5, the combined
suspended and adherent cells were collected using Cell Dissociation Buffer (Gibco) and then
differentiated ex vivo or sorted prior to transplantation into lethally irradiated recipients.
In vitro differentation of granulocytes following retroviral transduction of murine bone marrow
Neutrophils were differentiated in vitro from mock transduced or transduced BM cells by
culturing in alpha-MEM with 20% serum, 50 IU/ml murine IL-3, 0.3 ng/ml (=30IU/ml) human G-SCF,
and 2% penicillin/streptomycin in T75 flasks.  Every other day (on day 6, 8, 10, 12, and 14 post harvest)
cell number was counted, and cell density was adjusted to 5 x 105 cells/ml using fresh differentiation
media.  On day 8 through day 12, cells were selected by adding 2 µg/ml puromycin and by day 12, all
mock-transduced cells exposed to puromycin had died.  On day 14, cells were harvested for NADPH
oxidase assays, using either transduced cells selected with puromycin or mock-transduced cells cultured
in the absence of puromycin.  Diff-Quik stained cytospins on day 14 showed !80 - 90% mature
neutrophils, with no differences seen between WT, Rac2-null, or Rac-transduced cells.  The fraction of
Gr-1 positive cells as analyzed by flow cytometry was also similar between between different groups.
Cell lysate was prepared on day 14- 16 for SDS-PAGE and Western blotting.
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9Transplantation of retrovirus-transduced murine bone marrow cells
To generate neutrophils differentiated in vivo from MIEG vector-transduced BM cells, EGFP
positive cells were selected on day 5 of the transduction protocol by sorting with a FACStar instrument
(Becton Dickinson) and 0.5 – 1.0 x 106 sorted cells were injected via tail vein into Rac2-null mice that
had been irradiated with 1100 cGy (split dose).   Following hematopoietic recovery, neutrophils from
peripheral blood and BM were assessed by flow cytometry for EGFP marking at four to six weeks after
transplantation.  Neutrophils were then purified from BM as previously described (12,15) for analysis of
NADPH oxidase activity and motility.  In some experiments, BM from mice transplanted with sorted,
MIEG vector-transduced rac2-/- cells were used for secondary transplants into additional 1100cGy-
irradiated rac2-/- mice to generate additional in vivo differentiated neutrophils expressing exogenous Rac.
For rac2-/- controls, a group of rac2-/- mice were transplanted in parallel with freshly isolated rac2-/- BM
and used as a source of rac2-/- neutrophils in subsequent functional assays.  However, NADPH oxidase
activity and chemotaxis in neutrophils harvested from these mice were no different from neutrophils
harvested from non-transplanted rac2-/- mice.
Immunoblotting
Preparation of neutrophil lysates, SDS-PAGE, and immunoblotting were performed as described
(12,15,22).  Briefly, neutrophils differentiated in vitro or purified from BM were treated with
diisopropylphosphofluroidate prior to lysis with IP buffer (1% Triton X-100, 150 mM NaCl, 10 mM Tris-
Cl, 1 mM EDTA, 1 mM EGTA, pH 8.0) containing 20 µg/ml chymostatin, 2 mM PMSF, 10 µM
leupeptin, and 1 mM AEBSF.  Following SDS-PAGE and transfer to nitrocellulose membranes, blots
were sequentially probed with either an anti-Rac1 monoclonal mouse Ab, an anti-Rac2 rabbit polyclonal
Ab, and an anti-p38MAPK rabbit polyclonal Ab, followed by HRP-conjugated anti-mouse or anti-rabbit
IgG.  Proteins were visualized using an ECL detection kit (Amersham Pharmacia Biotech).  Bands were
scanned and the densities were analyzed by NIH image software (http://rsb.info.nih.gov/nih-image/).
 at Indiana U
niversity School of M
edicine on M
arch 27, 2014
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
10
Multiple exposures were analyzed to ensure that relative signal intensities measured were in the linear
range.
Measurement of NADPH oxidase activity
For quantitative assays, either isoluminol chemiluminescence or a colorimetric assay based on
reduction of cytochrome c was used to detect reactive oxygen species  (8,23).  Under these conditions,
superoxide dismutase inhibited the chemiluminescence signal by ~97.5% and cytochrome c reduction by
~100%.  Chemiluminescence in fMLP-stimulated cells was detected as relative luminescence units (RLU)
by fast kinetic mode for 100 sec using an Lmax microplate luminometer and SoftMax Pro software
(Molecular Devices, Sunnyvale, CA).  The rate of cytochrome c reduction was measured as Vmax using
SpectraMax340c microplate reader and the SoftMax PRO software (Molecular Devices, Sunnyvale, CA).
Chemotaxis
Neutrophil chemotaxis assays using 1 and 10 mM fMLP were performed using a modified
Boyden chamber (48-well microchemotaxis chamber, Neuro Probes, MD) and 3 mm diameter
polycarbonate filter membranes as described previously (8,15).  The number of migrated cells per high
power view field (400x) were counted for a minimum of three fields per well, and an average estimation
for individual sample was calculated from data of replicate wells. Values were compared relative to the
number of migrated cells in the WT group.
Time-lapse video microscopy and motility analysis
Neutrophil motility in response to fMLP stimulation was recorded using a Dunn chemotaxis
chamber (24).  BM neutrophils in HBSS were allowed to adhere to clean glass coverslips for 15 minutes
at 37!C.  The coverslips were mounted on the Dunn chamber with a gradient of 0-10 mM fMLP between
the inner and outer wells of the chamber.  The chamber was mounted on the microscope stage and the
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11
temperature maintained at 37!C with a stage heater (Instec Instruments, Boulder, CO).  The chamber was
allowed to equilibrate for 25 minutes prior to image collection to allow a stable gradient to develop.
Images were recorded at 10-second intervals on a Nikon Diaphot 300 microscope with differential
interference contrast optics using a SPOT cooled CCD camera.  Cell positions were tracked using the
particle tracking capabilities in Metamorph 6.1 software (Universal Imaging, Brandywine, PA). Cell
trajectories were analyzed using the horizon method (24,25), in which the position of the cell is marked
once it reaches a “horizon” at 30 mm from the initial position, and used to define the trajectory of the cell
relative to the orientation of the gradient.  This methodology can only be applied to cell types that move a
significant distance over the time period analyzed, and therefore directional data could not be obtained for
rac2-/- or Rac1-transduced rac2-/- cells.  Directionality was evaluated relative to the null hypothesis of
uniformity using the Rayleigh test (25).  In all cases over 350 cells of each type were analyzed.
Statistical analysis
The two-tailed Student's T test (either paired or unpaired, as indicated) was performed using Microsoft
Excel software (Redmond, WA).  Statistical comparisons of the distribution of rates of movement
between cell types were made using the Wilcoxon-Mann-Witney rank sum test with Kaleidagraph
software (Synergy Software, Reading, PA). Oriana software (Kovach Computing Services, Pentraeth,
Wales) was used to plot circular histograms and for statistical analysis of directional data.
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12
Results
Expression of recombinant Rac proteins in neutrophils differentiated in vitro
In initial studies, recombinant Rac proteins were expressed in rac2-/- neutrophils differentiated in
vitro.  Rac2-/- myeloid progenitor cells were transduced with MSCV-based retroviral vectors designed to
express Rac1 or Rac2.  In preliminary studies using MIEG-based retroviral vectors for transduction
followed by in vitro differentiation, recombinant Rac proteins were expressed at levels that were three- to
six -fold greater than endogenous levels in wild-type neutrophils.2  Therefore, subsequent in vitro studies
utilized the MSCV-pac backbone, which contains a linked antibiotic resistance gene, puromycin-N-
acetyl-transferase (pac) (Fig. 1b), where exogenous Rac proteins were not overexpressed (see below).
Vectors included those in which an epitope tag was placed on the amino-terminus of Rac (an HA tag for
Rac1 or a FLAG tag for Rac2) as well as those for expression of Rac1 or Rac2 without an epitope tag.
Following transduction, bone marrow cells were differentiated in vitro with G-CSF and IL-3 with or
without puromycin, as described in the Methods, with !80 - 90% morphologically mature neutrophils
present after 12 -14 days.  In the absence of selection, no differences in expansion or neutrophil
differentiation were observed between WT or rac2-/- BM that was either mock-transduced or transduced
with a control vector containing only the puromycin cassette.  There were also no significant differences
in expansion or neutrophil differentiation between puromycin-selected WT and rac2-/- cells transduced
with the control vector containing only the puromycin cassette, or in rac2-/- cells transduced with Rac-
containing vectors.
To evaluate expression of Rac isoforms in neutrophils differentiated in vitro, we performed
immunoblotting using antibodies specific for either Rac1 or Rac2 (Fig. 2a).  Recombinant Rac proteins
were expressed from the MSCV-pac vectors at ! 60% of endogenous levels, based on densitometric
analysis of blots from 4 independent experiments (not shown).  Placement of an epitope tag retarded the
migration of the recombinant Rac proteins, as expected (Fig. 2a), but did not affect the relative level of
expression.  Endogenous Rac1 levels in the in vitro differentiated rac2-/- neutrophils were not
significantly increased from wild-type levels (Fig. 2a).
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13
NADPH oxidase activity in wild type and rac2-/- neutrophils differentiated in vitro
Quantitative assessment of NADPH oxidase activity in neutrophils differentiated in vitro was
performed using a chemiluminescence assay to detect FMLP-induced production of reactive oxidants and
the cytochrome c reduction assay to measure superoxide production in cells stimulated with phorbol
myristate acetate (PMA).  Rac2-/- neutrophils had substantially reduced NADPH oxidase activity
compared to WT neutrophils (Fig. 2), as previously reported for neutrophils harvested either from the
bone marrow storage pool or from peritoneal exudate (8,12,15,26).  For both genotypes, there was no
significant difference in oxidant production between neutrophils derived from mock-transduced cells
compared to puromycin-selected cells transduced with the control MSCV-pac vector  (not shown).
Expression of either exogenous Rac1 or Rac2 increased NADPH oxidase activity in Rac2-null cells
stimulated with either FMLP or PMA.  The time course of oxidant production in representative
experiments is shown in Fig. 2b and c, and aggregate data is shown in Fig. 2d and e.  Of note, Rac
derivatives with an epitope tag had a reduced ability to rescue NADPH oxidase activity in rac2-/-
neutrophils compared to exogenous Rac proteins lacking a tag, although both epitope- and non-epitope-
tagged exogenous Rac proteins were expressed at similar levels (Fig. 2a).
Expression of Rac2 was consistently slightly more effective than exogenous Rac1 in enhancing
NADPH oxidase activity in rac2-/- neutrophils (eg. Fig 2b), although the difference in activity between the
Rac2- and Rac1-transduced groups did not reach statistical significance.  Only partial reconstitution of
NADPH oxidase activity was observed even in Rac2-transduced rac2-/- neutrophils, which may reflect the
fact that exogenous Rac proteins were expressed at only !60% of wild-type levels using the MSCV-pac
vectors (see above).  Neutrophils isolated from heterozygous rac2+/- BM, which have !one-half the level
of Rac2 protein compared to rac2+/+ neutrophils, also have reduced superoxide production compared to
wild-type neutrophils  (8).  Similarly, NADPH oxidase activity in rac2+/- neutrophils differentiated in
vitro as above is reduced by !25% or !50% following PMA or FMLP stimulation, respectively.2
Retrovirus-mediated expression of exogenous Rac1 and Rac2 in neutrophils differentiated in vivo
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14
We next examined whether expression of exogenous Rac1 or Rac2 in rac2-/- neutrophils
differentiated in vivo could reconstitute NADPH oxidase activity and motility.  The above results using
rac2-/- neutrophils differentiated in vitro with hematopoietic growth factors indicated that exogenous
expression of either isoform improved NADPH oxidase activity, with expression of exogenous Rac2 only
slightly more effective than Rac1.  GM-CSF or TNF-a treatment of neutrophils isolated from rac2-/- mice
can partially correct defective NADPH oxidase activity and chemoattractant-induced actin formation (15),
raising the question that exposure to pharmacologic concentrations of growth factors during the in vitro
differentiation process may have influenced these results.  Thus, we transplanted Rac-transduced rac2-/-
bone marrow cells into lethally irradiated rac2-/- mice in order to study function of neutrophils produced
in vivo.  Rac derivatives without epitope tags were utilized for these studies.
Initial transplant studies using the MSCV-pac vectors (Fig. 1b) showed that recombinant Rac
proteins were expressed at only !5% of wild-type levels in neutrophils produced in vivo (not shown).
Expression vectors for Rac1 and Rac2 based on the MIEG3 retrovirus (Fig. 1b) were next evaluated.
Flow cytometry for EGFP expression was used to select transduced cells by FACS prior to transplantation
into lethally irradiated rac2-/- recipients.   Following hematopoietic recovery, between 60 - 92% of
neutrophils were EGFP-positive in all but one mouse (a recipient of MIEG3-Rac1-transduced cells), with
most animals having at least 80% EGFP-positive neutrophils.  That fewer than 100% neutrophils were
EGFP-positive despite sorting for EGFP fluorescence prior to transplantation likely reflects provirus
silencing in a subset of transduced repopulating cells, as observed in other studies where transduced BM
cells are sorted ex vivo prior to transplantation (eg (27)).  As shown in a representative immunoblot in Fig.
3a, expression levels of exogenous Rac1 and Rac2 in neutrophils harvested from rac2-/- mice receiving
transduced marrow were similar to endogenous levels in rac2+/+ neutrophils.  An exception was one
recipient of MIEG3-Rac2-transduced BM, in which neutrophil expression of exogenous Rac2 was only
!35% of wild-type levels (not shown), which was excluded from the analyses of NADPH oxidase activity
and chemotaxis below.
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15
NADPH oxidase activity of rac2-/- neutrophils produced in vivo following transduction for expression of
Rac1 or Rac2
We examined NADPH oxidase activity in neutrophils harvested from rac2-/- mice
hematopoietically reconstituted with Rac-transduced rac2-/- BM cells and which had 60 - 92% EGFP-
positive neutrophils.  As shown in Fig. 3, expression of exogenous Rac2 in rac2-/- neutrophils restored
fMLP- and PMA-stimulated activity to wild type levels.  However, increased expression of Rac1 resulted
in a much smaller increase in oxidant production, and the time course of fMLP-stimulated oxidant
production resembled that of rac2-/- neutrophils, lacking the rapid onset of oxidant production
characteristic of fMLP-stimulated rac2+/+ neutrophils (Fig. 3b).  Taken together, these results indicate that
the Rac2 isoform is essential for normal NADPH oxidase activity in neutrophils produced in vivo, and
that increased expression of Rac1 cannot compensate for its absence in rac2-/- neutrophils.
NADPH oxidase activity in rac2-/- neutrophils expressing Rac1 and Rac2 derivatives chimeric for the
polybasic domain
Rac1 and Rac2 have the greatest sequence divergence in the polybasic domain adjacent to the
prenylation site (Fig. 1a).  To determine whether this domain could mediate isoform specificity in
NADPH oxidase activity in neutrophils produced in vivo, we utilized cDNAs in which the sequence
encoding the polybasic domain in Rac1 was replaced with the corresponding sequence from the human
Rac2 (referred to as Rac1-2), and vise versa (referred to as Rac2-1) (11) (Fig. 1a).   These cDNAs were
cloned into MIEG3 retroviral vectors (Fig. 1b), which were used to transduce rac2-/- BM cells.  Lethally
irradiated rac2-/- mice were transplanted as above with transduced cells sorted for EGFP expression.
EGFP-positive neutrophils in transplanted mice ranged from ! 75 - 100%, and expression levels of Rac1-
2 and Rac2-1 proteins were similar to endogenous Rac1 and Rac2 (Fig. 4a).  The mobility of the chimeric
Rac proteins was also similar to  endogenous Rac, consistent with normal prenylation of the chimeras.  Of
note, the polybasic domain appears to be the dominant epitope recognized by the Rac1 and Rac2
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antibodies used in this study, since the Rac1-2 protein was detected by the Rac2 antibody and the Rac2-1
protein was detected by the Rac1 antibody (Fig. 4a).
Analysis of NADPH oxidase activity in neutrophils harvested from rac2-/- mice transplanted with
Rac1-2 or Rac2-1-transduced marrow cells showed that the polybasic domain is sufficient to determine
isoform specificity (Fig. 4b, c).   fMLP- or PMA-stimulated NADPH oxidase activity in Rac1-2-
expressing rac2-/- neutrophils was similar to that observed for wild-type neutrophils, including the time
course of oxidant production, whereas expression of Rac2-1 produced only a very small, if any, increase
in NADPH oxidase activity.   Interestingly, NADPH oxidase activity in rac2-/- neutrophils expressing
exogenous Rac1 was greater than in rac2-/- cells expressing Rac2-1 (compare Fig. 3 and Fig. 4).
Chemotaxis in Rac-transduced rac2-/- neutrophils
We also analyzed chemotaxis in rac2-/- neutrophils and Rac-transduced rac2-/- neutrophils
harvested from bone marrow.  In Boyden chamber assays, expression of either the Rac2 isoform or the
Rac1-2 derivative containing the polybasic domain of Rac2 restored chemotaxis of rac2-/-neutrophils
towards fMLP (Fig. 5).  However, migration of rac2-/- neutrophils expressing either Rac2-1 or additional
Rac 1 was similar to control rac2-/- cells (Fig. 5).
We used time-lapse video microscopy to directly observe the motility of BM neutrophils
migrating in a linear gradient of fMLP established in a Dunn (24) chemotaxis chamber.  As previously
described and as shown in Fig. 6, Supplementary Fig.1, and accompanying movies in Supplementary
Figs. 2 and 3, few rac2-/- cells displayed directed movement (<7.5% moved at greater than 2 mm/min, vs.
>40% of WT cells, p<0.01, Wilcoxon rank sum test, N>350).  Expression of Rac2 was effective in
restoring chemotaxis in rac2-/- cells, whereas expression of Rac1 did not appreciably rescue motility (6%
>2 mm/min, similar to rac2-/-, p>0.05, Wilcoxon test) (Fig. 6a, Supplementary Fig. 1 and movies in
Supplementary Figs. 4 and 5; 33% >2 mm/min).  Expression of Rac1-2 was also effective in restoring
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motility in rac2-/- cells (Fig. 6b; 21% >2 mm/min), whereas Rac2-1 was ineffective (9% >2 mm/min, not
statistically different from rac2-/-, p>0.05, Wilcoxon test) (see also Supplementary Figs. 1, 6, and 7).
Analysis of the directionality of BM neutrophil chemotaxis (Fig. 6c) showed that expression of
Rac2 and Rac1-2 rescued directed migration of rac2-/- (p<0.01 relative to null hypothesis of uniformity
(non-directional migration), N=30, Rayleigh test (25)).  Migration was aligned with the orientation of the
gradient (mean vector relative to gradient (0!): Rac2, 15!; Rac1-2, 2!).  Neither rac2-/- nor Rac1-
transduced rac2-/- cells moved sufficiently far during the period of analysis to reach the 30 mm “horizon”
that would have permitted their directionality to be analyzed.  Movement of some Rac2-1-expressing
rac2-/- cells, however, was sufficient for analysis.  Remarkably, these Rac2-1 expressing cells clearly
lacked directionality in their movement (p>0.05, Rayleigh test, N=25)  (Fig. 6c; see also Supplementary
Fig. 1).
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Discussion
Genetic deletion of the hematopoietic-specific Rac2 GTPase produces a variety of defects in
different blood cell lineages, suggesting that this isoform plays a non-redundant role in regulating blood
cell functions despite concomitant expression of the highly homologous Rac1 isoform (15,20,28).
Comparison of Rac1 and Rac2 activation in chemoattractant-stimulated rac2+/+, rac2+/-, and rac2-/-
murine neutrophils suggests that these two isoforms have both differential activation and signaling
profiles, with !four-fold more Rac2-GTP detected compared to Rac1-GTP in fMLP-treated rac2+/+
neutrophils (8).  Furthermore, NADPH oxidase activity is intact in rac1-/- neutrophils, which also exhibit
only a modest impairment in chemotaxis compared to rac2-/- neutrophils (17).  Taken together, these
observations support the concept that the role of each isoform in regulating neutrophil functions is
distinct.  The current study was designed to directly address this hypothesis.  Wild type murine
neutrophils have similar amounts of Rac1 and Rac2, and total cellular levels of Rac are diminished by !2-
fold in rac2-/- neutrophils (8).  We found that increasing cellular Rac levels by retrovirus-mediated
expression of Rac2 in rac2-/- neutrophils in vivo restored NADPH activity and chemotaxis, whereas
expression of additional Rac1 only partially corrected these defects.  Moreover, isoform specificity could
be determined solely by sequences derived from the C-terminal polybasic domain that is adjacent to the
prenylation site.  A chimeric Rac1-2 protein in which the Rac1 polybasic domain was replaced with that
of human Rac2 functioned in a manner similar to Rac2 in reconstituting the NADPH oxidase and
chemotaxis in rac2-/- neutrophils, whereas expression of an analogous Rac2-1 chimera did not.
A variety of molecular mechanisms could potentially account for distinct roles of Rac1 and Rac2.
Although these two isoforms have an identical amino acid sequence in the effector domain, differences in
the flexibility of this loop identified in molecular modeling studies, presumably due to long-range effects
of divergent residues, may result in differential binding to Rac guanine nucleotide exchange factors or
downstream targets (9).  In addition, differences in a proline-rich region just N-terminal to the polybasic
domain determine relative interactions with the adaptor protein Crk (29) and those at positions 90, 107,
147, and 151 influence the ability of the Rho-inactivating toxin, Escherichia coli cytotoxic necrotizing
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factor 1, to preferentially degrade Rac1 compared to other Rac isoforms (30).  However, the results of the
current study indicate that the polybasic domain (residues 183 - 188) is sufficient to determine the relative
ability of Rac 1 and 2 to regulate superoxide production and chemotaxis in neutrophils.
The Rac polybasic domain has previously been shown to be an important determinant in a variety
of cellular processes.  In fibroblast and epithelial cell lines, the polybasic domain directs localization of
Rac1 and Rac2 (upon their activation or when expressed in excess of RhoGDI) to either the plasma
membrane or to perinuclear endosomal membranes, respectively (10).  Deletion of the polybasic domain
in Rac2 impairs its biologic activities in neutophils, which in conjunction with the CAAX motif directs
membrane localization (31).  The Rac1 polybasic domain contains a nuclear localization signal and Rac1
expression in the nucleus of cultured fibroblasts and epithelial cells has been reported, which may
regulate Rac1 levels via proteasome-mediated degradation (10,32,33). The polybasic domain can also
influence interactions with proteins that regulate Rac-GTP levels or are downstream targets of Rac.  For
example, Rac1 binds to and activates the serine-threonine kinase PAK1 more efficiently than Rac2, with
the converse observed in chimeric proteins in which the polybasic domains were swapped (11).
Phosphoinositide 5-kinase activation in epithelial cell lines is dependent on the C-terminal polybasic
domain of Rac1, to which it binds more efficiently compared to the Rac2 polybasic domain (29).  Co-
immunoprecipitation of Rac1 with the formin/diaphanous related protein FHOS is also mediated by its
polybasic domain (34).  Differences in the analogous hypervariable domain in the C-terminus of
mammalian Ras isoforms have also been shown to determine specifically in localization and interaction
partners (35).  Hence, the non-redundant role of Rac2 in regulating neutrophil responses could reflect
polybasic domain-mediated differences in the localization of activated Rac to subcellular membrane
compartments or micro domains, the relative affinities with proteins that regulate Rac activation or serve
as downstream targets, or a combination of these factors.
Although expression of Rac2 or Rac1-2 was required for full reconstitution of superoxide
production in rac2-/- neutrophils in vivo, expression of exogenous Rac1 did produce small improvements.
In rac2-/- neutrophils, Rac1 is already activated to a !three-fold greater extent compared to wild-type
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neutrophils (8), and the current results suggest that increased expression of this isoform can improve
phorbol ester- or fMLP-stimulated NADPH oxidase activity in rac2-/- neutrophils.  Rac1 was also recently
shown to be the predominant form of Rac in human monocytes, where it was suggested to function as the
main isoform for superoxide production elicited by PMA and other agonists (36).  Rac1 translocates to
monocyte membranes in response to PMA, fMLP or opsonized zymosan, and co-immunoprecipitates
with the p47phox and p67phox NADPH oxidase subunits upon opsonized zymosan stimulation (36).  Of
note, murine neutrophils with a combined deficiency of both Rac1 and Rac2 have extremely low
superoxide production (28).
Also noteworthy is that expression of the Rac2-1 chimera containing the Rac1 polybasic domain
did not increase NADPH oxidase activity in rac2-/- neutrophils, in contrast to the small improvements
seen with expression of exogenous Rac1.  In addition, rac2-/- neutrophils expressing Rac2-1 exhibited
disoriented cell motility.  The underlying basis for these observations remains to be determined.
However, the different responses when expressing exogenous Rac1 compared to Rac2-1 are not easily
understood in terms of a mechanism for isoform specificity that is based solely on polybasic domain-
directed localization of activated Rac.
Placement of an epitope tag on proteins is a useful strategy for distinguishing an exogenous
protein from endogenous.  Although not the focus of this report, it is of interest that placement of either
an HA or FLAG tag on the N-terminus of Rac1 and Rac2, respectively, blunted their ability to enhance
NADPH oxidase activity in rac2-/- neutrophils.  This suggests that these tags impaired Rac activation
and/or downstream signaling.  To our knowledge, this is the first time epitope tagging of a small GTPase
has been reported to interfere with its function, although most studies typically involve overexpression in
heterologous cell systems where such effects might be easily missed.
Results from this and our previous (8,12,15) studies indicate that Rac2 is a key regulator of
oxidant production and motility.  The assembled NADPH oxidase complex includes activated Rac, which
binds to p67phox and also likely to flavocytochrome b558 (2,37).  In the cell free NADPH oxidase system,
recombinant prenylated Rac1 and Rac2 have equal potential for activating NADPH oxidase using purified
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flavocytochrome b558 and recombinant cytosolic phox proteins (38).  Although NADPH oxidase activity
elicited by opsonized zymosan is unaffected in rac2-/- neutrophils, these cells exhibit decreased
superoxide production in response to fMLP, PMA or IgG-opsonized particles (8,12,15).   The agonist-
selective defects in NADPH oxidase activity in rac2-/- neutrophils suggest that Rac2 regulates upstream
events and/or is more efficiently incorporated into the oxidase complex compared to Rac1  in response to
these agonists.  The first scenario is supported by the observation that Rac2-null neutrophils have other
functional defects in response to agonists that are associated with reduced NADPH oxidase activity
(8,12,15).  The parallel effects of exogenous Rac1, Rac2, and chimeric Rac proteins on chemotaxis and
superoxide production by rac2-/- neutrophils in this study is also consistent with roles in shared signaling
pathways. 
Our observations also support a critical role for Rac2 in cell orientation in chemotaxis.  We
previously showed that rac2-/- cells, in addition to their impaired ability to move, are not polarized in the
direction of the chemotactic gradient (15). We show here that Rac1-2, as well as Rac2 itself, fully rescued
the ability of cells to move and, moreover, to properly orient their motility in a chemotactic gradient.
Rac2-1 cells displayed a greater defect in chemotaxis in Boyden chamber assays than the frequency and
speed of migrating Rac2-1 cells might predict, but the discrepancy can easily be explained by the
remarkably disoriented nature of their motility.  This is consistent with the accepted critical role for Rac
in chemotactic signaling pathways (39-41), and illuminates possible isoform-specific roles in this process
that have not previously been recognized. The Rac GTPases are proposed to be a component of a positive
feedback loop involving the GTPase and phosphatidylinositol 3-kinase that is important for establishment
of cell polarity and the maintenance of a “front-ness” signal at the leading edge (39,40).  Although we
were unable to definitively determine whether Rac1 expressing cells showed directed migration (due to
their poor motility and consequent failure to reach the 30 mm horizon required for the analysis), the
disoriented nature of the motile response displayed by Rac2-1 expressing cells is highly suggestive of a
critical role for factors that specifically interact with the Rac2 polybasic domain in establishing cell
 at Indiana U
niversity School of M
edicine on M
arch 27, 2014
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
22
polarity and orientation. Our results suggest the need for more work to determine interactions that specify
distinct roles for Rac1 and Rac2 in regulating the cytoskeleton in hematopoietic cells.
While this manuscript was in preparation, a study by Filippi and colleagues (42) reported findings
generally consistent with those described here, with a notable difference with respect to reconstitution of
neutrophil motility.  Similar to our results, migration of fMLP-stimulated rac2-/- neutrophils in Boyden
chambers was reconstituted by expression of Rac2.  However, rescue by a Rac1-2 chimera additionally
required replacement of a glycine at position 150 with aspartic acid, the residue at the corresponding
position in Rac2 (42).  This contrasts with our findings, where expression of a Rac1-2 chimera was
sufficient to reconstitute fMLP-stimulated chemotaxis in rac2-/- neutrophils (Fig. 5, 6).  However, the
study by Filippi et al used the murine Rac2 polybasic domain, which differs from the human Rac2
sequence used here, in having a proline instead of an alanine at position 188 (Fig. 1a).  Other factors that
may have contributed to the different results are that Filippi et al used neutrophils differentiated in vitro
and exogenous Rac proteins that were HA-tagged and relatively overexpressed (42).
Filippi and coworkers also reported differences in localization of EGFP-tagged Rac proteins in
murine neutrophils, which may contribute to their different functions (42).  In resting cells, EGFP-Rac1
was dispersed compared to a more central cytoplasmic and perinuclear localization for EGFP-Rac2.
Upon fMLP stimulation both forms were also detected at more peripheral locations, with Rac1 co-
localizing with cortical actin and Rac2 being somewhat more interior.  Moreover, in fMLP-stimulated
rac2-/- neutrophils, EGFP-Rac1 was poorly organized, suggesting that there may be crosstalk between the
two Rac isoforms.  Since deficient F-actin formation is a notable feature of fMLP-stimulated rac2-/-
neutrophils (15), Filippi et al proposed that Rac1 distribution may be correlated to F-actin organization
and that Rac1 dysfunction in rac2-/- neutrophils might contribute to their abnormal chemotaxis.  We are
currently undertaking studies to examine Rac1 and Rac2 localization in neutrophils isolated from bone
marrow or peripheral blood.  In preliminary studies on unstimulated murine neutrophils stained with Rac1
and Rac2 antibodies or expressing small amounts of exogenous EGFP-Rac1 or EGFP-Rac2, both
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isoforms were distributed diffusely in the cytosol.3  These results are consistent with studies on resting
human neutrophils, where Rac2 is cytosolic and in a complex with RhoGDI (43), but differ from the
localization described by Filippi and coworkers (see above) (42).  However, Rac proteins were relatively
overexpressed in the latter studies, possibly exceeding Rho-GDI binding capacity (10), and also studied in
neutrophils differentiated in vitro using relatively high concentrations of growth factors.  Neither we3 nor
Fillipi et al (42) detected a significant pool of nuclear Rac1 in neutrophils.
In conclusion, these results establish that Rac2 plays a non-overlapping role with Rac1 to regulate
neutrophil chemotaxis and NADPH oxidase activity, and demonstrate that the C-terminal polybasic
domain is sufficient for conferring this specificity.  Future studies will address underlying mechanisms
that discriminate between Rac1 and Rac2, which may include differences in subcellular targeting as well
as binding to interacting regulatory or downstream target proteins.
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Footnotes
1  The abbreviations used are PAK, p21-activated kinase; PAC, puromycin-N-acetyl-transferase; IRES,
internal ribosome entry sequence; EGFP, enhanced green fluorescent protein; SCF, stem cell factor;
MDGF, megakaryocyte-derived growth factor; AEBSF, 4-(2-Aminoethyl)-bezenesulfonylfluoride.HCl;
Ab, antibody; PMA, phorbol myristate acetate
2  A. Yamauchi and M. Dinauer, unpublished data.
3  S. Atkinson, A. Yamauchi and M. Dinauer, unpublished data
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Figure Legends
Figure 1.  C-terminus of Rac proteins and retroviral vectors for expression of Rac.
A.  Sequence alignment of the C-terminus of wild type Rac1, Rac2, and derivatives.  Hyphens indicate
sites where amino acid residues are identical to wild type murine Rac1, whereas differences are as
indicated. The polybasic domain is indicated by a rectangle.  Mu, murine; hu, human.  Note that the entire
murine Rac1 and human Rac1 amino acid sequence are identical.  B. MSCV-PAC and MIEG3 retroviral
vectors.   The genes between long terminal repeats (LTR) are shown. PGK, phosphoglyceroyl kinase; pac,
puromycin-N-acetyl-transferase; H, HA epitope tag; F, Flag epitope tag, IRES, internal ribosome entry
site; EGFP, enhanced green fluorescent protein.
Figure 2.  Rac expression and NADPH oxidase activity in neutrophils differentiated in vitro.
After transduction with MSCV-pac retrovirus vectors, or mock-transduction, murine bone marrow cells
were cultured with IL-3 and G-CSF for differentiation in vitro as described in Methods.  MSCV-pac
retrovirus-transduced cells were selected in puromycin.  Wild type, rac2-/-, or rac2-/- cells expressing
exogenous Rac proteins are as indicated.  Emp, empty (MSCV-Pac lacking a Rac cDNA); R1, Rac1;
HR1, HA-tagged Rac1; R2, Rac2; FR2, Flag-tagged Rac2.   A. Immunoblot of extracts prepared from in
vitro-differentiated neutrophils, using anti-Rac1, anti-Rac2 or anti-p38MAPK, as indicated.  Note that
epitope tagged Rac proteins migrated slightly slower than untagged Rac proteins, and Rac1-transduced
rac2-/- cells contain both endogenous and exogenous Rac1.   Representative of 4 experiments.  B, C.
Representative time course of ROS production by in vitro differentiated neutrophils detected by
chemiluminescence (for fMLP-stimulated cells, B) or reduction of cytochrome c (PMA-stimulated
superoxide production, C).  RLU, relative luminescence units.  mOD, optical density (x 10-3).  D, E.
Quantitative analysis of NADPH oxidase activity in in vitro differentiated neutrophils.  Superoxide
dismutase- inhibitable luminescence (integrated RLU over 100 sec) is shown for fMLP-elicited ROS
production (D).  The maximal rate of superoxide dismutase- inhibitable cytochrome c reduction (Vmax)
is shown for PMA-elicited superoxide production.  Means ± SEM are shown; N = 9 for WT and rac2-/-
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controls; N =3 -6 for Rac-transduced rac2-/- cells.  ‡ p < 0.02 (vs rac2-/- emp), ‡‡ p < 0.005 (vs rac2-/-
emp), # p <0.01 (vs R2, paired test, n " 3).   ** p = 0.057 (vs rac2-/- emp). p values except R2 vs FR2 are
based on unpaired student’s t-test.
Figure 3.  Rac expression and NADPH oxidase activation of neutrophils isolated from WT, rac2-/-,
and rac2-/- mice transplanted with Rac1- or Rac2- transduced BM.
Rac2-/- BM was transduced with MIEG3 retroviral vectors for expression of either Rac1 or Rac2, sorted
for EGFP-positive cells, and transplanted into rac2-/- mice as described in Methods.  Immunoblots and
NADPH oxidase assays were performed on freshly isolated neutrophils from transplanted mice.  Rac2-/-
control mice were transplanted with untransduced rac2-/- BM.  Wild type, rac2-/-, or rac2-/- cells
expressing exogenous Rac proteins are as indicated, and abbreviations are as in Fig. 2.  A.  Immunoblot of
extracts prepared from BM neutrophils, using anti-Rac1, anti-Rac2 or anti-p38MAPK, as indicated.
Representative of 3 experiments.  Note that the antibody for Rac2 has some cross reactivity with
Rac1,(15) which accounts for the faint band in Rac1-transduced rac2-/- extracts probed for Rac2.  B, C.
Representative time course of neutrophil ROS production detected by chemiluminescence (for fMLP-
stimulated cells, B) or reduction of cytochrome c (PMA-stimulated superoxide production, C).  RLU,
relative luminescence units.  mOD, optical density (x 10-3).  The fraction of EGFP-positive neutrophils
for Rac1- and Rac2-transduced rac2-/- neutrophils was 84% and 92%, respectively.  D, E.  Quantitative
analysis of neutrophil NADPH oxidase activity.  Superoxide dismutase- inhibitable luminescence
(integrated RLU over 100 sec) is shown for fMLP-elicited ROS production (D).  The maximal rate of
superoxide dismutase- inhibitable cytochrome c reduction (Vmax) is shown for PMA-elicited superoxide
production.  Means ± SEM are shown.   N = 14 and 8 for WT and rac2-/- controls, respectively.   N = 3 for
Rac-transduced rac2-/- neutrophils.  * p < 0.05 (vs rac2-/-), ** p < 0.00005 (vs rac2-/- ), # p < 0.02 (vs
WT), ## p < 0.0005 (vs  WT). p values are based on unpaired student’s t-test.
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Figure 4.  Rac expression and NADPH oxidase activation of neutrophils isolated from WT, rac2-/-,
and rac2-/- mice transplanted with Rac1-2- or Rac2-1- transduced BM.
Experimental design and abbreviations are as described in Fig. 3.  A.  Immunoblot of extracts prepared
from freshly isolated neutrophils, using  anti-Rac1, anti-Rac2 or anti-p38MAPK, as indicated.
Representative of 4 experiments.  B, C. Representative time course of neutrophil ROS production
detected by chemiluminescence (for fMLP-stimulated cells, B) or reduction of cytochrome c (PMA-
stimulated superoxide production, C).  RLU, relative luminescence units.  mOD, optical density (x 10-3).
The fraction of EGFP-positive neutrophils for Rac1-2- and Rac2-1-transduced rac2-/- neutrophils was
83% and 80%, respectively.  D, E.  Quantitative analysis of neutrophil NADPH oxidase activity.
Superoxide dismutase- inhibitable luminescence (integrated RLU over 100 sec) is shown for fMLP-
elicited ROS production (D).  The maximal rate of superoxide dismutase- inhibitable cytochrome c
reduction (Vmax) is shown for PMA-elicited superoxide production.  Means ± SEM are shown.   N = 14
and 8 for WT and rac2-/- controls, respectively.   N= 3 –5 for Rac-transduced rac2-/- cells.  * p < 0.0002
(vs rac2-/- ), **p < 0.00001 (vs  rac2-/- ).  p values are based on unpaired student’s t-test.
Figure 5.  Chemotaxis of neutrophils isolated from WT, rac2-/-, and Rac2-/- transplanted with Rac-
transduced BM.    
Experimental design and abbreviations are as described in Fig. 3 and 4.  Chemotaxis assays performed on
freshly isolated neutrophils, using a modified Boyden chamber in response to 1mM or 10 mM fMLP as
described in Methods.  The ligand was loaded in the lower wells and the cells (2 x 105) were loaded in
upper wells separated by a 3 mm pore size filter membrane, followed by incubation at 37!C for 45 min.
The number of migrated cells was subsequently counted by microscopic examination.  Results are
expressed as the percentage of migrated cells per field compared to WT control neutrophils.  Means ±
SEM are shown. *p < 0.002 (vs rac2-/-); **p < 0.0005 (vs rac2-/-).   p values are based on unpaired
student’s t-test (n " 3).
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Figure 6. Videomicroscopy analysis of fMLP-induced motility in neutrophils isolated from WT, rac2-
/-, and Rac2-/- transplanted with Rac-transduced BM.   
Freshly isolated neutrophils were exposed to a linear gradient of 0-10 mM fMLP in a Dunn chemotaxis
chamber and the positions of cells were recorded at 10-second intervals over a 15-minute period.  See also
accompanying movies S2-6, and supplementary Fig. S1. A. Histogram of the mean speed distribution of
WT, rac2-/-, and Rac1 and Rac2 transduced rac2-/- cells.  Data were derived from three independent
experiments.  B.  Histogram of the mean speed distribution of WT, rac2-/- and Rac1-2 and Rac2-1
transduced rac2-/- cells. Data were derived from three independent experiments. C. Circular histograms
showing the distributions of cell trajectories of WT cells or rac2-/- cells transduced with Rac2, Rac1-2 or
Rac2-1 relative to the orientation of the gradient (0!).  Plots show the mean direction and 95% confidence
limit for the trajectories where there was a significant non-uniform distribution. Each plot shows a
representative experiment from a total of three independent experiments with similar results.
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Legends for Supplementary Data Yamauchi et al.
Supplementary Figure S1
Representative tracks for individual WT, rac2-/- or rac transduced rac2-/- BM neutrophils
moving in a gradient of 0-10mM fMLP. The plots show the tracks of 15 randomly chosen
cells from representative experiments relative to the cell’s initial position at the first time
point analyzed. The concentration of fMLP increases from left to right. Data are
representative of three independent experiments.  Note that although the distance traveled
by several of the Rac1-2-transduced cells shown in Fig. S1 was greater that for the Rac2-
transduced cells shown, overall there was no difference in the speed frequency
distribution between these two groups (See Fig. 6A).
Supplementary Figures S2-S7
Representative time-lapse movies of murine neutrophils migrating in a gradient of 0-
10mM fMLP, with the concentration of fMLP increasing from left to right across the
field. Movies are 120x real time, field of view is 230x230µm.
S2. Wild type
S3. Rac2-/-
S4. Rac1 expressing rac2-/- cells.
S5. Rac2 expressing rac2-/- cells.
S6. Rac1-2 expressing rac2-/- cells.
S7. Rac2-1 expressing rac2-/- cells.
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Figure S2. WT motility
Figure S7. KO+R2-1 motilityFigure S6. KO+R1-2 motility
Figure S5. KO+R2 motilityFigure S4. KO+R1 motility
Figure S3. KO motility
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